β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE‐HF): a double blind, placebo‐controlled, randomized clinical trial.
Saved in:
| Title: | β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE‐HF): a double blind, placebo‐controlled, randomized clinical trial. |
|---|---|
| Authors: | García‐Álvarez, Ana1,2,3,4 (AUTHOR) anagarci@clinic.cat, Blanco, Isabel2,5,6 (AUTHOR), García‐Lunar, Inés3,4,7 (AUTHOR), Jordà, Paloma1 (AUTHOR), Rodriguez‐Arias, Juan J.1 (AUTHOR), Fernández‐Friera, Leticia3,4,8 (AUTHOR), Zegri, Isabel9 (AUTHOR), Nuche, Jorge3,4,10 (AUTHOR), Gomez‐Bueno, Manuel4,11 (AUTHOR), Prat, Susanna1,2 (AUTHOR), Pujadas, Sandra9 (AUTHOR), Sole‐Gonzalez, Eduard1 (AUTHOR), Garcia‐Cossio, Maria D.4,10 (AUTHOR), Rivas, Mercedes9,11 (AUTHOR), Torrecilla, Estefanía1 (AUTHOR), Pereda, Daniel2,3,4,12 (AUTHOR), Sanchez, Javier3,13 (AUTHOR), García‐Pavía, Pablo3,4,11 (AUTHOR), Segovia‐Cubero, Javier4,11 (AUTHOR), Delgado, Juan F4,10 (AUTHOR) |
| Source: | European Journal of Heart Failure. Mar2023, Vol. 25 Issue 3, p373-385. 13p. 2 Diagrams, 5 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13889842 |
|---|---|
| DOI: | 10.1002/ejhf.2745 |
